Salzman & Co’s Abbott ABT Stock Holding History

Salzman & Co’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-172,060	Closed	-$7.64M	–	4
2017 Q1	$7.64M	Buy	+172,060	New	+$7.44M	20.03%	3

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Salzman & Co's ABT Position: Q2 2017 in Review

Salzman & Co sold out of Abbott (ABT) in Q2 2017, closing a stake of 172,060 shares — an estimated $7.64M sold.

Salzman & Co first reported a position in ABT in Q1 2017 and held it in 1 quarter. The position peaked at $7.64M in Q1 2017. 1,576 funds tracked by Wall St. Rank hold ABT as of Q2 2017.

Salzman & Co reported no remaining Abbott position as of Q2 2017 after selling out during the quarter.
Salzman & Co sold 172,060 Abbott shares in Q2 2017, an estimated $7.64M.
Salzman & Co first reported a position in Abbott in Q1 2017 and held it in 1 quarter.
Salzman & Co's Abbott position peaked at $7.64M in Q1 2017.
1,576 funds tracked by Wall St. Rank held Abbott as of Q2 2017.

Based on Salzman & Co's 13F filing for Q2 2017, filed 14 Aug 2017.